Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ST2, a Novel Biomarker for Cardiac Remodeling in Adults With Congenital Heart Disease

NCT01774890 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT01774890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01774890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ST2, a Novel Biomarker for Cardiac Remodeling in Adults With Congenital Heart Disease
Lead sponsor
Hadassah Medical Organization
Phase
Observational
Overall status
Completed
Start date
March 31, 2013
Completion date
January 31, 2017
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart disease